ICON plc to Present at Baird's 2019 Global Healthcare Conference
September 03 2019 - 4:15PM
Business Wire
ICON plc, (NASDAQ: ICLR) a global provider of drug and device
development and commercialisation services to the pharmaceutical,
biotechnology and medical device industries, today announced that
Dr. Steve Cutler, CEO and Mr. Brendan Brennan, CFO of ICON plc,
will present at Baird’s 2019 Global Healthcare Conference on
Thursday, September 5, 2019. The presentation will be webcast live
from 1.25pm EDT.
A live webcast will be available via the Investor section of our
website under “Events”.
About ICON plc
ICON plc is a global provider of drug development solutions and
services to the pharmaceutical, biotechnology and medical device
industries. The company specialises in the strategic development,
management and analysis of programs that support clinical
development - from compound selection to Phase I-IV clinical
studies. With headquarters in Dublin, Ireland, ICON employed
approximately 14,400 employees in 98 locations in 40 countries as
at June 30, 2019. Further information is available at
www.iconplc.com.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
ICON/ICLR-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190903005795/en/
Investor Relations +1888 381 7923 or Jonathan Curtain Vice
President Corporate Finance and Investor Relations +353 1 291
2000
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Mar 2024 to Apr 2024
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Apr 2023 to Apr 2024